Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review

Int J Mol Sci. 2021 Sep 17;22(18):10037. doi: 10.3390/ijms221810037.

Abstract

Cardiotoxicity is a frequent undesirable phenomenon observed during oncological treatment that limits the therapeutic dose of antitumor drugs and thus may decrease the effectiveness of cancer eradication. Almost all antitumor drugs exhibit toxic properties towards cardiac muscle. One of the underlying causes of cardiotoxicity is the stimulation of oxidative stress by chemotherapy. This suggests that an appropriately designed diet or dietary supplements based on edible plants rich in antioxidants could decrease the toxicity of antitumor drugs and diminish the risk of cardiac failure. This comprehensive review compares the cardioprotective efficacy of edible plant extracts and foodborne phytochemicals whose beneficial activity was demonstrated in various models in vivo and in vitro. The studies selected for this review concentrated on a therapy frequently applied in cancer, anthracycline antibiotic-doxorubicin-as the oxidative stress- and cardiotoxicity-inducing agent.

Keywords: anthracyclines; antioxidants; cardioprotectants; cardiotoxicity; phytochemicals.

Publication types

  • Review

MeSH terms

  • Animals
  • Anthracyclines / metabolism
  • Antioxidants / metabolism
  • Biological Products / metabolism*
  • Doxorubicin / pharmacology
  • Humans
  • Phytochemicals / metabolism

Substances

  • Anthracyclines
  • Antioxidants
  • Biological Products
  • Phytochemicals
  • Doxorubicin